Cleerly ISCHEMIA vs eMurmur Heart AI
AI Verdict
Choose Cleerly ISCHEMIA if…
Choose Cleerly ISCHEMIA if you require a detailed, non-invasive assessment of coronary artery disease and the likelihood of ischemia based on CCTA imaging. This tool is ideal for physicians needing to understand vessel-level ischemia, characterize coronary plaque, and assess stenosis severity to guide personalized treatment plans. It provides comprehensive structural and functional insights from advanced cardiac imaging.
View Cleerly ISCHEMIA →Choose eMurmur Heart AI if…
Choose eMurmur Heart AI if your primary need is automated analysis of heart and lung sounds for screening, monitoring, and remote consultation. This platform is best suited for healthcare providers looking to detect and classify heart murmurs, gain hemodynamic insights, and track changes in auscultation data over time, particularly in telehealth or general practice settings. It offers a convenient, hardware-neutral solution for sound-based diagnostics.
View eMurmur Heart AI →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Cleerly ISCHEMIA | eMurmur Heart AI |
|---|---|---|
| Pricing | Unknown | Contact for quote |
| Deployment | Web-based solution | Web-based, Mobile App, API integration |
| BAA Available | Yes AI-estimated | Yes AI-estimated |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
eMurmur Heart AIeMurmur Heart AI offers superior usability due to its mobile app availability (iOS, Android), hardware-neutral platform, and support for live streaming and remote auscultation, making it highly adaptable for diverse clinical settings and telehealth. Cleerly ISCHEMIA, while offering a web-based platform and integration with radiology systems, lacks the same breadth of access and flexibility for point-of-care use.
Clinical Value
Cleerly ISCHEMIACleerly ISCHEMIA provides highly specific and quantitative insights from CCTA, including non-invasive fractional flow reserve (FFR) estimation and detailed coronary plaque characterization, which are critical for personalized diagnosis and treatment planning in coronary artery disease. While eMurmur Heart AI offers valuable objective auscultation analysis for screening and monitoring, it is explicitly stated as not a sole means of diagnosis, indicating a more supportive rather than definitive diagnostic role.
Pricing & Value
Cleerly ISCHEMIAWhile both tools require direct contact for pricing, Cleerly ISCHEMIA benefits from a recently established Category I CPT code (75577) with a defined Medicare reimbursement rate of $1,026, offering a clearer path for billing and demonstrating a recognized economic value for providers. This provides more transparency regarding its financial viability compared to eMurmur Heart AI, for which no similar reimbursement information is readily available.
Enterprise Readiness
TieBoth tools demonstrate strong enterprise readiness, being FDA-cleared, HIPAA compliant, and offering BAAs, which are foundational for secure healthcare IT environments. Cleerly ISCHEMIA provides specific integration with radiology systems like PowerScribe via API, while eMurmur Heart AI offers broad cloud-based deployment, mobile access, and API integration for telehealth and EHRs, indicating robust capabilities for diverse healthcare IT environments.
Innovation
Cleerly ISCHEMIACleerly ISCHEMIA demonstrates higher innovation by providing non-invasive fractional flow reserve (FFR) estimation and detailed coronary plaque characterization from CCTA scans, offering functional and anatomical insights that traditionally required more invasive methods. While eMurmur Heart AI's automated auscultation is innovative for standardizing a subjective exam, Cleerly's capabilities represent a more significant advancement in diagnostic precision for complex cardiac conditions.
Support & Docs
Cleerly ISCHEMIACleerly ISCHEMIA provides a more structured support system with dedicated client support forms and specified operating hours (Monday-Friday, 10 am-6 pm ET) for existing users. While eMurmur Heart AI offers a general support email address for inquiries, Cleerly's formalized approach suggests a potentially more responsive and organized support experience for its users.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Cleerly ISCHEMIA | eMurmur Heart AI |
|---|---|---|
| Core Function / Input Data | Analyzes CCTA scans to determine the likelihood of coronary artery ischemia at a vessel level. | Analyzes heart and lung sounds to detect murmurs and provide hemodynamic insights. |
| Company | Cleerly | CSD Labs |
| Tagline | AI-Powered Precision for Non-Invasive Ischemia Detection | Auscultation AI for healthier hearts & lungs. |
| Primary Medical Specialties | Cardiology, Radiology | Cardiology, Internal Medicine, Pulmonology |
| Key Analysis Capabilities | AI-enabled CCTA analysis, Non-invasive fractional flow reserve (FFR) estimation, Vessel-level ischemia likelihood determination, Coronary plaque characterization, Stenosis severity assessment. | Automated heart and lung sound analysis (S1, S2, murmurs, crackles, wheezes), Detection and classification of pathologic and innocent heart murmurs, Hemodynamic insights. |
| Remote Capabilities | Data transfer via Cleerly Proxy (VPN or virtual appliance) | Mobile app (iOS, Android) and web portal for access, Live streaming and remote auscultation for telehealth. |
Videos
Demos, reviews, and walkthroughs featuring Cleerly ISCHEMIA and eMurmur Heart AI.
Frequently Asked Questions
More Comparisons
More matchups featuring Cleerly ISCHEMIA or eMurmur Heart AI
Backers
Who funded each tool's parent company.